An assay-development case compared laboratory standards for measuring two over-the-counter drugs.
Why a labeled benzodiazepine appeared
The investigators assessed several candidate internal standards, including diazepam-d5, for quantifying dextromethorphan and diphenhydramine in a fatal intoxication case. The chosen standard was diphenhydramine-d3 based on validation performance.
An internal standard is introduced as part of laboratory measurement. Its appearance in the methods does not establish that the person consumed the corresponding unlabeled medicine or that a benzodiazepine contributed to the death.
Selection needs experimental support
Chemical similarity and retention time can guide a candidate choice, but extraction recovery, matrix effects, precision, and accuracy must be evaluated. The paper found that the candidates did not perform identically. A labeled standard for one drug is not automatically optimal for a different analyte.
For report interpretation, distinguish specimen findings from reagents added during testing. This paper contributes an assay-validation example, with no basis for inferring diazepam exposure solely from the listed analytical materials.
Source paper
Original analysis of the supplied journal article, identified as PMC12858462.
Leave a Reply